Combined trabeculotomy and trabeculectomy with MMC in primary congenital glaucoma

Objective To investigate the long-term outcome of combined trabeculotomy and tra-beculectomy with mitomycin C (MMC) in primary congenital glaucoma (PCG). Methods We retrospective reviewed 24 eyes in 18 children diagnosed as PCG and underwent combined trabeculotomy and trabeculectomy with MMC from January 2002 to December 2008. Results Mitomycin (0.2-0.4 mg/mL) was used in all eyes. Average postoperative follow-up was 36.50 ± 20.09 months. Mean postoperative IOP was 16.75± 3.92 mmHg at last review and average decreasing 15.2 ± 5.8 mmHg (P < 0.01). No severe complication was recorded. Conclusions Combined trabeculotomy and trabeculectomy with MMC is a safe and viable treatment in PCG. MMC may prompt the success rate of surgery. Key words: Trabeculotomy;  Trabeculectomy;  Mitomycin C;  Primary congenital glaucoma